Europe drug discovery market was valued at $14.8 billion in 2020 and will grow by 8.3% annually over 2020-2030 owing the rising demand for specialty medicines, the surge in lifestyle-oriented diseases and the advancements in technology, the growing elderly population and the rising healthcare expenses, rising expenditure on R&D, and expiration of patents.Highlighted with 36 … Read more
North America drug discovery market is expected to grow by 7.9% annually in the forecast period and reach $41.44 billion by 2030 driven by the rising demand for specialty medicines, the surge in lifestyle-oriented diseases and the advancements in technology, the growing elderly population and the rising healthcare expenses, rising expenditure on R&D, and expiration … Read more
Global drug discovery market will reach $117.6 billion by 2030, growing by 8.6% annually over 2020-2030 driven by the rising demand for specialty medicines, the surge in lifestyle-oriented diseases and the advancements in technology, the growing elderly population and the rising healthcare expenses, rising expenditure on R&D, and expiration of patents.Highlighted with 86 tables and … Read more
Asia Pacific biosimilars market will grow by 30.7% annually with a total addressable market cap of $140.4 billion over 2021-2030 owing to the affordability of biosimilar-based treatment, rising incidence of chronic diseases due to aging populations, patent expirations of many blockbuster drugs, and better healthcare provisions.Highlighted with 33 tables and 56 figures, this 116-page report … Read more
Europe biosimilars market was valued at $5,847.6 million in 2020 and will grow by 23.1% annually over 2020-2030 owing to the affordability of biosimilar-based treatment, rising incidence of chronic diseases due to aging populations, patent expirations of many blockbuster drugs, and better healthcare provisions.Highlighted with 37 tables and 57 figures, this 121-page report “Europe Biosimilars … Read more
North America biosimilars market is expected to grow by 25.1% annually in the forecast period and reach $27.57 billion by 2030 driven by the affordability of biosimilar-based treatment, rising incidence of chronic diseases due to aging populations, patent expirations of many blockbuster drugs, and better healthcare provisions.Highlighted with 29 tables and 54 figures, this 116-page … Read more
Global biosimilars market will reach $113.25 billion by 2030, growing by 25.7% annually over 2020-2030 driven by the affordability of biosimilar-based treatment, rising incidence of chronic diseases due to aging populations, patent expirations of many blockbuster drugs, and better healthcare provisions.Highlighted with 89 tables and 90 figures, this 180-page report “Global Biosimilars Market 2020-2030 by … Read more
Asia Pacific enteral nutrition market will grow by 10.3% annually with a total addressable market cap of $44.18 billion over 2021-2030 owing to the increasing incidence of malnutrition, rising number of patients suffering with chronic diseases, and surge in adoption of enteral nutrition over parenteral nutrition due to lower cost and complications of enteral nutrition.Highlighted … Read more
Global injectable drugs market will reach $1,037.7 billion by 2030, growing by 9.8% annually over 2020-2030 driven by the increasing prevalence of chronic diseases, rising use of self-administered Injectable formulations, technological advancements in drug development, and growing approvals of new injectable drugs such as COVID-19 vaccines.Highlighted with 82 tables and 86 figures, this 165-page report … Read more
Asia Pacific CRISPR Gene Editing market will grow by 28.6% annually with a total addressable market cap of $21.45 billion over 2022-2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, … Read more